opentrade on Kalshi ↗

event6 outcomes

When will Beam Therapeutics submit a BLA for Risto-cel?

Kalshi·Science and Technology·ends Apr 8, 2027

As of 07:10 UTC on 6 Nov 2026, the highest-priced of the 6 markets in “When will Beam Therapeutics submit a BLA for Risto-cel?” on Kalshi are “before April 2027” at 69%, “before 2027” at 49% (+6pp in 24h) and “before December” at 23% (-1pp in 24h). The event has $745 in Kalshi-reported 24-hour volume. pdata.world compares it with 24 related events on Kalshi, Polymarket and Manifold.

vol cum

$26.9k

vol 24h

$745

outcomes

6

ends

Apr 8, 2027

outcomesclick to inspect →

showing 5 of 6

marketselected outcome

before April 2027

rank #1

United States

69¢

· 0.0pp

24h change

vol cum

$2.6k

vol 24h

$0

spread

0.06

ends

Apr 8, 2027

If Beam Therapeutics Inc. submits a BLA for Ristoglogene autogetemcel (risto-cel) to the FDA before Apr 1, 2027, then the market resolves to Yes.

timeline

opened · Mar 24, 2026opencloses · Apr 8, 2027

before April 2027 · prices over time

−24h

now

volume · by outcomehover a column to inspect

no volume history

similar markets

suggested by pdata

Kalshi

When will the FDA approve Intellia Therapeutics' lonvo-z?

Before 202889¢Before July 202787¢Before October 202787¢· 0.0pp

$0 24h · 3 markets

Polymarket

FDA approves Retatrutide this year?

yes3¢▲ 0.1pp

$136 24h · 1 market

Manifold

Will AOH1996 succeed in Phase I trial?

M0 24h · 1 market

Kalshi

FDA decision: Ralinepag by United Therapeutics (on or before June 24, 2027)

$0 24h · 1 market

Polymarket

Skin cancer vaccine BLA submitted by...?

June 30, 2027?92¢· 0.0ppMarch 31, 202754¢· 0.0pp

$8.4k 24h · 2 markets

Manifold

Will the VLA15 Lyme Disease vaccine "pass" its phase 3 human trial?

M0 24h · 1 market